FDA Approves Lurbinectedin Combo for ES-SCLC Maintenance

The approval is for a first-line combination maintenance therapy for extensive-stage SCLC.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-approves-lurbinectedin-combo-es-sclc-maintenance-2025a1000qnn?src=rss

Author :

Publish date : 2025-10-03 19:10:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

FDA Approves Lurbinectedin Combo for ES-SCLC Maintenance

Benefit of Dual Antiplatelet Therapy Murky in Valve-in-Valve Intervention

FDA Approves Maintenance Combo for Small Cell Lung Cancer

Related Posts

‘It’s Not How a Responsible Scientist Acts’: What We Heard This Week

Pain Patients Often Feel Out of Options. Acupuncture Hides in Plain Sight.

Trump and Republicans Once More Face a Tough Political Fight Over Obamacare

Extinct animals in Prehistoric Planet: Ice Age make it a must-watch

‘It sounds dramatic – but singing class saved by life’

Is Chemo Driving Late Cardiac Events in Older Cancer Survivors?

‘It’s Not How a Responsible Scientist Acts’: What We Heard This Week

Pain Patients Often Feel Out of Options. Acupuncture Hides in Plain Sight.

Trump and Republicans Once More Face a Tough Political Fight Over Obamacare

Extinct animals in Prehistoric Planet: Ice Age make it a must-watch

‘It sounds dramatic – but singing class saved by life’

Is Chemo Driving Late Cardiac Events in Older Cancer Survivors?

Potassium in Patients with ICDs; mRNA Flu Vaccine; Canceled NIH Funding for Trials

The FDA Commissioner Is Missing the Point of Advisory Committees

Categories

Archives